BIOVF Statistics
Total Valuation
BIOVF has a market cap or net worth of 11.87 billion. The enterprise value is 13.20 billion.
| Market Cap | 11.87B |
| Enterprise Value | 13.20B |
Important Dates
The next estimated earnings date is Thursday, February 5, 2026.
| Earnings Date | Feb 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 344.66M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -1.02% |
| Shares Change (QoQ) | -0.73% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 219.31M |
Valuation Ratios
The trailing PE ratio is 8,606.93 and the forward PE ratio is 20.19.
| PE Ratio | 8,606.93 |
| Forward PE | 20.19 |
| PS Ratio | 4.02 |
| PB Ratio | 3.11 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 15.26 |
| P/OCF Ratio | 15.16 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.24, with an EV/FCF ratio of 16.95.
| EV / Earnings | 9,565.23 |
| EV / Sales | 4.50 |
| EV / EBITDA | 7.24 |
| EV / EBIT | 17.57 |
| EV / FCF | 16.95 |
Financial Position
The company has a current ratio of 1.02, with a Debt / Equity ratio of 0.38.
| Current Ratio | 1.02 |
| Quick Ratio | 0.69 |
| Debt / Equity | 0.38 |
| Debt / EBITDA | 0.78 |
| Debt / FCF | 1.85 |
| Interest Coverage | 8.01 |
Financial Efficiency
Return on equity (ROE) is 0.01% and return on invested capital (ROIC) is 8.53%.
| Return on Equity (ROE) | 0.01% |
| Return on Assets (ROA) | 6.41% |
| Return on Invested Capital (ROIC) | 8.53% |
| Return on Capital Employed (ROCE) | 13.47% |
| Revenue Per Employee | 1.56M |
| Profits Per Employee | 730 |
| Employee Count | 1,806 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 1.41 |
Taxes
| Income Tax | -74.82M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +12.88% in the last 52 weeks. The beta is 0.29, so BIOVF's price volatility has been lower than the market average.
| Beta (5Y) | 0.29 |
| 52-Week Price Change | +12.88% |
| 50-Day Moving Average | 28.82 |
| 200-Day Moving Average | 23.47 |
| Relative Strength Index (RSI) | 61.20 |
| Average Volume (20 Days) | 595 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BIOVF had revenue of 2.96 billion and earned 1.38 million in profits. Earnings per share was 0.00.
| Revenue | 2.96B |
| Gross Profit | 2.31B |
| Operating Income | 757.21M |
| Pretax Income | -74.29M |
| Net Income | 1.38M |
| EBITDA | 1.82B |
| EBIT | 757.21M |
| Earnings Per Share (EPS) | 0.00 |
Balance Sheet
The company has 110.26 million in cash and 1.44 billion in debt, giving a net cash position of -1.33 billion.
| Cash & Cash Equivalents | 110.26M |
| Total Debt | 1.44B |
| Net Cash | -1.33B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 3.82B |
| Book Value Per Share | 11.08 |
| Working Capital | 26.85M |
Cash Flow
In the last 12 months, operating cash flow was 783.31 million and capital expenditures -4.99 million, giving a free cash flow of 778.32 million.
| Operating Cash Flow | 783.31M |
| Capital Expenditures | -4.99M |
| Free Cash Flow | 778.32M |
| FCF Per Share | n/a |
Margins
Gross margin is 78.16%, with operating and profit margins of 25.62% and 0.05%.
| Gross Margin | 78.16% |
| Operating Margin | 25.62% |
| Pretax Margin | -2.51% |
| Profit Margin | 0.05% |
| EBITDA Margin | 61.72% |
| EBIT Margin | 25.62% |
| FCF Margin | 26.33% |
Dividends & Yields
BIOVF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.02% |
| Shareholder Yield | n/a |
| Earnings Yield | 0.01% |
| FCF Yield | 6.55% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BIOVF has an Altman Z-Score of 3.21 and a Piotroski F-Score of 7.
| Altman Z-Score | 3.21 |
| Piotroski F-Score | 7 |